JP2021523200A5 - - Google Patents

Info

Publication number
JP2021523200A5
JP2021523200A5 JP2020564158A JP2020564158A JP2021523200A5 JP 2021523200 A5 JP2021523200 A5 JP 2021523200A5 JP 2020564158 A JP2020564158 A JP 2020564158A JP 2020564158 A JP2020564158 A JP 2020564158A JP 2021523200 A5 JP2021523200 A5 JP 2021523200A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
solvate
acceptable salt
compound according
alkyl
Prior art date
Application number
JP2020564158A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019222266A5 (https=
JP2021523200A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/032289 external-priority patent/WO2019222266A1/en
Publication of JP2021523200A publication Critical patent/JP2021523200A/ja
Publication of JPWO2019222266A5 publication Critical patent/JPWO2019222266A5/ja
Publication of JP2021523200A5 publication Critical patent/JP2021523200A5/ja
Ceased legal-status Critical Current

Links

JP2020564158A 2018-05-15 2019-05-14 Magl阻害剤 Ceased JP2021523200A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862671985P 2018-05-15 2018-05-15
US62/671,985 2018-05-15
PCT/US2019/032289 WO2019222266A1 (en) 2018-05-15 2019-05-14 Magl inhibitors

Publications (3)

Publication Number Publication Date
JP2021523200A JP2021523200A (ja) 2021-09-02
JPWO2019222266A5 JPWO2019222266A5 (https=) 2022-06-01
JP2021523200A5 true JP2021523200A5 (https=) 2022-06-01

Family

ID=68534223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564158A Ceased JP2021523200A (ja) 2018-05-15 2019-05-14 Magl阻害剤

Country Status (25)

Country Link
US (3) US11332453B2 (https=)
EP (1) EP3793547A4 (https=)
JP (1) JP2021523200A (https=)
KR (1) KR20210010475A (https=)
CN (1) CN112088001A (https=)
AR (1) AR115092A1 (https=)
AU (1) AU2019271123A1 (https=)
BR (1) BR112020000863A2 (https=)
CA (1) CA3097063A1 (https=)
CL (1) CL2020002927A1 (https=)
CO (1) CO2020013550A2 (https=)
CR (1) CR20200545A (https=)
DO (1) DOP2020000207A (https=)
EA (1) EA202092586A1 (https=)
GE (2) GEP20227443B (https=)
JO (1) JOP20200276A1 (https=)
MA (1) MA52635A (https=)
MX (1) MX2020012158A (https=)
NI (1) NI202000080A (https=)
PE (1) PE20211385A1 (https=)
PH (1) PH12020551934A1 (https=)
SG (1) SG11202011228TA (https=)
TW (1) TW201946906A (https=)
WO (1) WO2019222266A1 (https=)
ZA (1) ZA202006327B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20141702A1 (es) 2012-01-06 2014-11-19 Abide Therapeutics Inc Compuestos de carbamato y preparacion y uso de los mismos
US10899737B2 (en) 2016-09-19 2021-01-26 Lundbeck La Jolla Research Center, Inc. Piperazine carbamates and methods of making and using same
EP3793565B1 (en) 2018-05-14 2022-01-05 Gilead Sciences, Inc. Mcl-1 inhibitors
GEP20227443B (en) 2018-05-15 2022-11-25 H Lundbeck As Magl inhibitors
PE20210368A1 (es) 2018-06-27 2021-02-26 Eth Zuerich Nuevos compuestos de piridina y pirazina como inhibidores del receptor cannabinoide 2
JP7456948B2 (ja) 2018-06-27 2024-03-27 エフ. ホフマン-ラ ロシュ アーゲー 放射性標識カンナビノイド受容体2リガンド
CN112119068A (zh) 2018-06-27 2020-12-22 豪夫迈·罗氏有限公司 作为大麻素受体2的抑制剂的新型氮杂环丁烷-取代的吡啶和吡嗪化合物
CA3125636A1 (en) * 2019-01-25 2020-07-30 H. Lundbeck A/S Methods of treating disease with magl inhibitors
TWI778443B (zh) 2019-11-12 2022-09-21 美商基利科學股份有限公司 Mcl1抑制劑
KR20220101095A (ko) * 2019-11-15 2022-07-19 하. 룬드벡 아크티에셀스카브 Magl 억제제의 결정형
CN114787139B (zh) 2019-11-26 2025-03-11 吉利德科学公司 用于制备mcl1抑制剂的方法和中间体
WO2021214550A1 (en) 2020-04-21 2021-10-28 H. Lundbeck A/S Synthesis of a monoacylglycerol lipase inhibitor
EP4247783A1 (en) 2020-11-19 2023-09-27 Gilead Sciences, Inc. Processes and intermediates for preparing macrocyclic mcl1 inhibitors
EP4198023A1 (en) 2021-12-16 2023-06-21 Basf Se Pesticidally active thiosemicarbazone compounds
CA3242372A1 (en) 2021-12-29 2023-07-06 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
US20250197358A1 (en) 2022-02-17 2025-06-19 Basf Se Pesticidally active thiosemicarbazone compounds
EP4665718A1 (en) 2023-02-13 2025-12-24 Apogee Pharmaceuticals, Inc. Small molecules as monoacylglycerol lipase (magl) inhibitors, compositions and use thereof

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1593586A (https=) 1967-10-17 1970-06-01
JPS6183073A (ja) 1984-10-01 1986-04-26 Oki Electric Ind Co Ltd 印字装置の用紙送り方法
WO1989011794A1 (fr) 1988-06-07 1989-12-14 Rikagaku Kenkyusho Inhibiteur de la croissance de plantes
EP0619804B1 (en) 1991-11-27 1996-05-22 E.I. Du Pont De Nemours And Company Herbicidal acylated amino-(phenyl- or pyridinyl- or thienyl-)-phenyl derivatives
DE69408873T2 (de) 1993-12-22 1998-07-09 Shell Int Research Verfahren zur herstellung von carbamaten
WO1997018196A1 (en) 1995-11-15 1997-05-22 Zeneca Limited Herbicidal substituted pyrazole compounds
AU3440597A (en) 1996-07-02 1998-01-21 Novartis Ag N-phenylimino heterocyclic derivatives and their use as herbicides
RU2167150C2 (ru) 1998-03-25 2001-05-20 Фокин Александр Васильевич Полифторалкил-n-арилкарбаматы, обладающие антимикробной активностью
AU7855900A (en) 1999-10-04 2001-05-10 University Of Medicine And Dentistry Of New Jersey Methods for identifying rna binding compounds
EP1201298A1 (en) 2000-10-24 2002-05-02 Urea Casale S.A. Carbamate condensation unit
DE10348022A1 (de) 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
FR2864080B1 (fr) 2003-12-23 2006-02-03 Sanofi Synthelabo Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
WO2005063698A1 (en) 2003-12-31 2005-07-14 Council Of Scientific & Industrial Research Process for preparing carbamates
BRPI0507499A (pt) 2004-02-18 2007-07-24 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável ou hidrato dos mesmos, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir a ativação de receptores de mglur 5
US7786113B2 (en) 2004-12-23 2010-08-31 Hoffman-La Roche Inc. Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
AR055831A1 (es) 2004-12-30 2007-09-12 Janssen Pharmaceutica Nv Pepirazinilureas y piperidinilureas como moduladores de hidrolasa de amida de acidos grasos
WO2007052023A2 (en) 2005-11-05 2007-05-10 Astrazeneca Ab Novel compounds
JP2009523729A (ja) 2006-01-13 2009-06-25 ピーティーシー セラピューティクス,インコーポレーテッド C型肝炎の治療方法
WO2008078091A1 (en) 2006-12-22 2008-07-03 Astex Therapeutics Limited Bicyclic heterocyclic compounds as fgfr inhibitors
US7795457B2 (en) 2007-02-26 2010-09-14 Kosan Biosciences Incorporated Carbamate compounds
US8188098B2 (en) 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
JP2011528368A (ja) 2008-07-16 2011-11-17 シェーリング コーポレイション 二環式ヘテロ環誘導体およびgpcrモジュレーターとしてのその使用
WO2010056309A2 (en) 2008-11-14 2010-05-20 The Scripps Research Institute Methods and compositions related to targeting monoacylglycerol lipase
WO2010111050A1 (en) 2009-03-23 2010-09-30 Banyu Pharmaceutical Co., Ltd. Novel aminopyridine derivatives having aurora a selective inhibitory action
US8455476B2 (en) 2009-04-22 2013-06-04 Janssen Pharmaceutica, Nv Azetidinyl diamides as monoacylglycerol lipase inhibitors
UA107791C2 (en) 2009-05-05 2015-02-25 Dow Agrosciences Llc Pesticidal compositions
ES2433235T3 (es) 2009-11-03 2013-12-10 Bayer Intellectual Property Gmbh Fluorouretanos como aditivos en una formulación de fotopolímero
FR2960875B1 (fr) 2010-06-04 2012-12-28 Sanofi Aventis Derives de carbamates d'hexafluoroisopropyle, leur preparation et leur application en therapeutique
NZ627096A (en) 2012-01-06 2017-02-24 Agios Pharmaceuticals Inc Triazinyl compounds and their methods of use
PE20141702A1 (es) 2012-01-06 2014-11-19 Abide Therapeutics Inc Compuestos de carbamato y preparacion y uso de los mismos
CA2866302A1 (en) 2012-03-19 2013-09-26 Abide Therapeutics, Inc. Carbamate compounds and of making and using same
JP2014005245A (ja) 2012-06-26 2014-01-16 Dainippon Sumitomo Pharma Co Ltd 二環性ピリミジン誘導体を含有する医薬組成物
US9551036B2 (en) 2013-02-25 2017-01-24 Whitehead Institute For Biomedical Research Metabolic gene mesenchymal signatures and uses thereof
JP6647592B2 (ja) 2013-07-03 2020-02-14 ルンドベック ラ ホーヤ リサーチ センター,インク. ピロロピロールカルバメート、および関連する有機化合物、医薬組成物、ならびにその医学的使用
US10570146B2 (en) 2014-07-25 2020-02-25 Northeastern University Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof
JP2018513119A (ja) 2015-03-18 2018-05-24 アビデ セラピューティクス,インク. ピペラジンカルバメート、およびピペラジンカルバメートを製造ならびに使用する方法
US10899737B2 (en) 2016-09-19 2021-01-26 Lundbeck La Jolla Research Center, Inc. Piperazine carbamates and methods of making and using same
MA46866B1 (fr) 2016-11-16 2021-11-30 H Lundbeck As Une forme cristalline d'un inhibiteur de magl
JOP20190105A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
JOP20190106A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
CN111032034B (zh) * 2017-08-29 2023-05-02 H.隆德贝克有限公司 螺环化合物及其制造和使用方法
GEP20227443B (en) 2018-05-15 2022-11-25 H Lundbeck As Magl inhibitors
CA3125636A1 (en) 2019-01-25 2020-07-30 H. Lundbeck A/S Methods of treating disease with magl inhibitors

Similar Documents

Publication Publication Date Title
JP2021523200A5 (https=)
RU2019116512A (ru) Ингибиторы magl
JP2021514001A5 (https=)
JP2020169171A5 (https=)
JP2024050527A5 (https=)
JPWO2019222266A5 (https=)
RU2019116514A (ru) Ингибиторы magl
JP2019531279A5 (https=)
JP2020502047A5 (https=)
JP2008510770A5 (https=)
JP2020532545A5 (https=)
JP2016534148A5 (https=)
JP2018504437A5 (https=)
JP2015532295A5 (https=)
JP2019524883A5 (https=)
JP2018529650A5 (https=)
RU2020107039A (ru) Спироциклические соединения и способы их получения и применения
JP2022141692A5 (https=)
JP2017508816A5 (https=)
JP2020504184A5 (https=)
JPWO2019165358A5 (https=)
JP2021521178A5 (https=)
JP2007531742A5 (https=)
JP2012518634A5 (https=)
JP2020111571A5 (https=)